Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type i diabetes mellitus and their close family members

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 633-639

  Krause, Ilan ^a,b,c   Anaya, Juan Manuel ^d   Fraser, Abigail ^e   Barzilai, Ori ^a   Ram, Maya ^a   Abad, Verónica ^f   Arango, Alvaro ^g   García, Jorge ^h   Shoenfeld, Yehuda ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^g Clinica Universitaria Bolivariana   (Colombia)

^h Antioqueña de Diabetes   (Colombia)

Author keywords

Autoimmunity; Celiac disease; Cytomegalovirus; Epstein Barr virus; Helicobacter pylori; Infection; Toxoplasma

Indexed keywords

AUTOANTIBODY; BACTERIUM ANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; CYTOMEGALOVIRUS ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; EPSTEIN BARR VIRUS ANTIBODY; GLIADIN ANTIBODY; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HELICOBACTER PYLORI ANTIBODY; HEPATITIS B VIRUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; JO 1 ANTIBODY; LA ANTIBODY; MYELOPEROXIDASE ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEINASE 3 ANTIBODY; PROTHROMBIN ANTIBODY; PROTOZOON ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; RUBELLA ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY; TOXOPLASMA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; CELIAC DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIABETIC PATIENT; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FAMILY; FEMALE; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INFECTION SENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RUBELLA; TOXOPLASMA; TREPONEMA PALLIDUM;

CYTOMEGALOVIRUS; HELICOBACTER PYLORI; HUMAN HERPESVIRUS 4; TOXOPLASMA;

EID: 69949184384     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04619.x     Document Type: Conference Paper

References (51)

1. Liu, E. et al. 2002. Type 1A diabetes mellitus-associated autoimmunity. Endocrinol. Metab. Clin. North Am. 31: 391-410.
2. Pozzilli, P. et al. 1998. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based study. Metab. Clin. Exp. 47: 1205-1210.
3. Levin, L. et al. 2003. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun. Rev. 2: 377-386.
4. Adeghate, E. et al. 2006. An update on the etiology and epidemiology of diabetes mellitus. Ann. N. Y. Acad. Sci. 1084: 1-29.
5. Cohen, I.R. 2004. Thoughts on the pathogenesis of type 1 diabetes and on the arrest of autoimmune beta-cell destruction by peptide p277 vaccination. Isr. Med. Assoc. J. 6: 260-261.
6. Shoenfeld, Y. et al. 2008. The mosaic of autoimmu-nity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr. Med. Assoc. J. 10: 8-12. (Pubitemid 351649455)
7. Shoenfeld, Y. et al. 2008. The mosaic of autoim-munity: genetic factors involved in autoimmune diseases-2008. Isr. Med. Assoc. J. 10: 3-7. (Pubitemid 351649454)
8. Richer, M.J. et al. 2008. Viral infections in the patho-genesis of autoimmune diseases: focus on type 1 diabetes. Front. Biosci. 13: 4241-4257.
9. Roivainen, M. et al. 1998. Several different en-terovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. J. Med. Virol. 56: 74-78.
10. Verge, C.F. et al. 1994. Environmental-factors in childhood IDDM-a population-based, case-control study. Diab. Care 17: 1381-1389.
11. Tobon, G.J. et al. 2006. Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population. Diab. Res. Clin. Pract. 72: 170-175.
12. Anaya, J.M. et al. 2006. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J. Autoimmun. 26: 208-214.
13. Shovman, O. et al. 2005. Evaluation of the BioPleX (TM) 2200 ANA screen-Analysis of 510 healthy subjects: Incidence of natural/predictive autoantibodies. Ann. N. Y. Acad. Sci. 1050: 380-388.
14. Zandman-Goddard, G. et al. 2008. Neuropsychiatric lupus and infectious triggers. Lupus 17: 380-384.
15. Pordeus, V. et al. 2008. A latitudinal gradient study of common anti-infectious agent antibody prevalence in Italy and Colombia. Isr. Med. Assoc. J. 10: 65-68.de Luis, D.A. et al. 1998. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diab. Res. Clin. Pract. 39: 143-146.
16. Marrollo, M. et al. 2001. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig. Liver Dis. 33: 21-29.
17. Pocecco, M. et al. 1997. High risk of Helicobacter pylori infection associated with cow's milk antibodies in young diabetics. Acta Paediatr. 86: 700-703.
18. Dore, M.P. et al. 2000. Diabetes mellitus and Heli-cobacter pylori infection. Nut. 16: 407-410.
19. Gasbarrini, A. et al. 1998. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur. J. Gastroenterol. Hepatol. 10: 469-472.
20. Xia, H.H.X. et al. 2001. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am. J. Gastroenterol. 96: 1039-1046.
21. Mallecki, M. et al. 1996. The prevalence of Heli-cobacter pylori infection and types of gastritis in diabetic patients. The Krakow Study. Exp. Clin. En-docrinol. Diab. 104: 365-369.
22. Pak, C.Y. et al. 1988. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2: 1-4.
23. Pak C.Y. et al. 1990. Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell au-toantibody. Diabetologia 33: 569-572.
24. Hiemstra, H.S. et al. 2001. Cytomegalovirus in au-toimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA 98: 3988-3991.
25. Parkkonen, P. et al. 1994. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group. Clin. Exp. Immunol. 95: 287-293.
26. Surcel, H.M. et al. 1988. Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes. Acta Paediatr. Scand. 77: 471-474.
27. Hyoty, H. et al. 1991. Decreased antibody reactivity to Epstein-Barr-Virus capsid antigen in type-1 (insulin-dependent) diabetes-mellitus. Apmis 99: 359-363.
28. Yoon, J.W. et al. 2002. Viruses in the pathogenesis of type 1 diabetes. In Textbook of Diabetes, 3rd edn. J. Pickup & G. Williams, Eds.: 1. Blackwell Scientific. London.
29. Dyrberg, T. et al. 1988. Inhibition of diabetes in BB rats by virus infection. J. Clin. Invest. 81: 928-931.
30. Oldstone, M.B. 1988. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 239: 500-502.
31. Like, A.A. et al. 1991. Influence of environmental viral agents on frequency and tempo of diabetes mel-litus in BB/Wor rats. Diabetes 40: 259-262.
32. Hermitte, L. et al. 1990. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of en-cephalomyocarditis virus. Eur. J. Immunol. 20: 1297-1303.
33. Wilberz, S. et al. 1991. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 34: 2-5.
34. Takei, I. et al. 1992. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J. Autoimmun. 5: 665-673.
35. Oldstone M.B. 1990. Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J. Exp. Med. 171: 2077-2089.
36. Barnett, A.H. et al. 1981. Diabetes in identical twins. A study of 200 pairs. Diabetologia 20: 87-93.
37. Notkins, A.L. 2004. Type 1 diabetes as a model for autoantibodies as predictors of autoimmune diseases. Autoimmun. Rev. 3(Suppl 1): S7-9.
38. Wasserfall, C.H. et al. 2006. Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun. Rev. 5: 424-428.
39. Badenhoop, K. et al. 2004. Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease. Exp. Clin. Endocrinol. Diab. 112: 407-415.
40. Betterle, C. et al. 1984. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 26: 431-436.
41. Perros, P. et al. 2000. Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease. Diab. Med. 17: 749-751.
42. Briani, C. et al. 2008. Celiac disease: From gluten to autoimmunity. Autoimmun. Rev. 7: 644-650.
43. Fasano, A. et al. 2001. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120: 636-651.
44. Reif, S. et al. 2004. Tissue transglutaminase-the key player in celiac disease: a review. Autoimmun. Rev. 3: 40-45.
45. Bizzaro, N. et al. 2003. Association of celiac disease with connective tissue diseases and autoimmune diseases of the digestive tract. Autoimmun. Rev. 2: 358-363.
46. Shaoul, R. et al. 2007. Associated autoantibodies in celiac disease. Autoimmun. Rev. 6: 559-565.
47. Dieterich, W. et al. 2000. Serum antibodies in celiac disease. Clin. Lab. 46: 361-364.
48. Kordonouri, O. et al. 2000. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus. Diab. Med. 17: 441-444.
49. Harrison, L.C. et al. 2008. Type 1 diabetes: Lessons for other autoimmune diseases? J. Autoimmun. 31: 306-310.
50. Richer M.J. et al. 2008. Viral infections in the patho-genesis of autoimmune diseases: focus on type 1 diabetes. Front. Biosci. 13: 4241-4257.
51. Knip, M. et al. 2008. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev. 7: 550-557.